Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

NCI-COG Pediatric MATCH (Molecular Analysis for Therapy Choice) Screening Protocol

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT03155620
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:27:55.534556+00:00
Published At
2026-04-14T00:00:00+00:00
Record Updated At
2026-04-14
Results Posted At
2026-04-14
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Advanced Malignant Solid Neoplasm", "Ann Arbor Stage III Non-Hodgkin Lymphoma", "Ann Arbor Stage IV Non-Hodgkin Lymphoma", "Histiocytic Sarcoma", "Juvenile Xanthogranuloma", "Langerhans Cell Histiocytosis", "Malignant Glioma", "Recurrent Childhood Rhabdomyosarcoma", "Recurrent Ependymoma", "Recurrent Ewing Sarcoma", "Recurrent Glioma", "Recurrent Hepatoblastoma", "Recurrent Langerhans Cell Histiocytosis", "Recurrent Malignant Germ Cell Tumor", "Recurrent Malignant Solid Neoplasm", "Recurrent Medulloblastoma", "Recurrent Neuroblastoma", "Recurrent Non-Hodgkin Lymphoma", "Recurrent Osteosarcoma", "Recurrent Peripheral Primitive Neuroectodermal Tumor", "Recurrent Primary Central Nervous System Neoplasm", "Recurrent Rhabdoid Tumor", "Recurrent Soft Tissue Sarcoma", "Refractory Ewing Sarcoma", "Refractory Glioma", "Refractory Hepatoblastoma", "Refractory Langerhans Cell Histiocytosis", "Refractory Malignant Germ Cell Tumor", "Refractory Malignant Solid Neoplasm", "Refractory Medulloblastoma", "Refractory Neuroblastoma", "Refractory Non-Hodgkin Lymphoma", "Refractory Osteosarcoma", "Refractory Peripheral Primitive Neuroectodermal Tumor", "Refractory Primary Central Nervous System Neoplasm", "Refractory Rhabdoid Tumor", "Refractory Rhabdomyosarcoma", "Rhabdoid Tumor", "Stage III Osteosarcoma AJCC v7", "Stage III Soft Tissue Sarcoma AJCC v7", "Stage IV Osteosarcoma AJCC v7", "Stage IV Soft Tissue Sarcoma AJCC v7", "Stage IVA Osteosarcoma AJCC v7", "Stage IVB Osteosarcoma AJCC v7", "Wilms Tumor"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2026-04-14"
protocolSection.identificationModule.nctId
"NCT03155620"
protocolSection.identificationModule.officialTitle
"NCI-COG Pediatric MATCH (Molecular Analysis for Therapy Choice) Screening Protocol"
protocolSection.statusModule.overallStatus
"ACTIVE_NOT_RECRUITING"
protocolSection.designModule.phases
["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2026-04-14"

Study condition terms

  • Advanced Malignant Solid Neoplasm (protocolSection.conditionsModule.conditions)
  • Ann Arbor Stage III Non-Hodgkin Lymphoma (protocolSection.conditionsModule.conditions)
  • Ann Arbor Stage IV Non-Hodgkin Lymphoma (protocolSection.conditionsModule.conditions)
  • Histiocytic Sarcoma (protocolSection.conditionsModule.conditions)
  • Juvenile Xanthogranuloma (protocolSection.conditionsModule.conditions)
  • Langerhans Cell Histiocytosis (protocolSection.conditionsModule.conditions)
  • Malignant Glioma (protocolSection.conditionsModule.conditions)
  • Recurrent Childhood Rhabdomyosarcoma (protocolSection.conditionsModule.conditions)
  • Recurrent Ependymoma (protocolSection.conditionsModule.conditions)
  • Recurrent Ewing Sarcoma (protocolSection.conditionsModule.conditions)
  • Recurrent Glioma (protocolSection.conditionsModule.conditions)
  • Recurrent Hepatoblastoma (protocolSection.conditionsModule.conditions)
  • Recurrent Langerhans Cell Histiocytosis (protocolSection.conditionsModule.conditions)
  • Recurrent Malignant Germ Cell Tumor (protocolSection.conditionsModule.conditions)
  • Recurrent Malignant Solid Neoplasm (protocolSection.conditionsModule.conditions)
  • Recurrent Medulloblastoma (protocolSection.conditionsModule.conditions)
  • Recurrent Neuroblastoma (protocolSection.conditionsModule.conditions)
  • Recurrent Non-Hodgkin Lymphoma (protocolSection.conditionsModule.conditions)
  • Recurrent Osteosarcoma (protocolSection.conditionsModule.conditions)
  • Recurrent Peripheral Primitive Neuroectodermal Tumor (protocolSection.conditionsModule.conditions)
  • Recurrent Primary Central Nervous System Neoplasm (protocolSection.conditionsModule.conditions)
  • Recurrent Rhabdoid Tumor (protocolSection.conditionsModule.conditions)
  • Recurrent Soft Tissue Sarcoma (protocolSection.conditionsModule.conditions)
  • Refractory Ewing Sarcoma (protocolSection.conditionsModule.conditions)
  • Refractory Glioma (protocolSection.conditionsModule.conditions)
  • Refractory Hepatoblastoma (protocolSection.conditionsModule.conditions)
  • Refractory Langerhans Cell Histiocytosis (protocolSection.conditionsModule.conditions)
  • Refractory Malignant Germ Cell Tumor (protocolSection.conditionsModule.conditions)
  • Refractory Malignant Solid Neoplasm (protocolSection.conditionsModule.conditions)
  • Refractory Medulloblastoma (protocolSection.conditionsModule.conditions)
  • Refractory Neuroblastoma (protocolSection.conditionsModule.conditions)
  • Refractory Non-Hodgkin Lymphoma (protocolSection.conditionsModule.conditions)
  • Refractory Osteosarcoma (protocolSection.conditionsModule.conditions)
  • Refractory Peripheral Primitive Neuroectodermal Tumor (protocolSection.conditionsModule.conditions)
  • Refractory Primary Central Nervous System Neoplasm (protocolSection.conditionsModule.conditions)
  • Refractory Rhabdoid Tumor (protocolSection.conditionsModule.conditions)
  • Refractory Rhabdomyosarcoma (protocolSection.conditionsModule.conditions)
  • Rhabdoid Tumor (protocolSection.conditionsModule.conditions)
  • Stage III Osteosarcoma AJCC v7 (protocolSection.conditionsModule.conditions)
  • Stage III Soft Tissue Sarcoma AJCC v7 (protocolSection.conditionsModule.conditions)
  • Stage IV Osteosarcoma AJCC v7 (protocolSection.conditionsModule.conditions)
  • Stage IV Soft Tissue Sarcoma AJCC v7 (protocolSection.conditionsModule.conditions)
  • Stage IVA Osteosarcoma AJCC v7 (protocolSection.conditionsModule.conditions)
  • Stage IVB Osteosarcoma AJCC v7 (protocolSection.conditionsModule.conditions)
  • Wilms Tumor (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.